DOJ secures $305 million in penalties to resolve generics case

Ben Remaly

22 August 2023

The Department of Justice has agreed to defer its price-fixing prosecution of Teva Pharmaceuticals after the generic drugmaker agreed to pay the largest domestic cartel fine in US history and divest a cholesterol medication.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

Bidding adieu to bid competition: The Tipline for 4 December 2023
Procompetitive bid-rigging? The US Court of Appeals for the Fourth Circuit may have upended criminal antitrust enforcement on Friday. A three-judge panel threw out the Sherman Act conviction of a sales manager because the court said his company also had a vertical relationship with its bid-rigging co-conspirator. Also in Tipline, assistant attorney general Jonathan Kanter is given another airline merger to challenge.
Could have been an email: The Tipline for 1 December 2023
Take two: The Tipline for 30 November 2023

DOJ secures $305 million in penalties to resolve generics case

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Ben Remaly